Dr. Shashwatee Bagchi is an Associate Professor with clinical, research and administrative roles in the Clinical Research and the Virology Clinic within the Division of Infectious Diseases.
Dr. Bagchi specializes in clinical and translational research with a focus on cardiometabolic and vascular complications of infections. Her current research projects focus on understanding the biology and immune pathways driving coronary inflammation and high-risk plaque features among those with HIV and HCV, with the goal of identifying potential therapeutic interventions to mitigate or prevent cardiac complications in these persons. Dr. Bagchi has a passion for working with underserved populations, and has worked extensively with persons with HIV, HCV and tuberculosis both in the U.S. and overseas. She has spent much of her time helping to build the HIV workforce in Zambia and Tanzania as well as expanding and strengthening health systems in both inpatient and outpatient health facilities. Additionally, she enjoys training and mentoring the next generation of clinical educators, clinician scientists, and leaders who will help improve the health of marginalized populations. Dr. Bagchi firmly believes that complex questions require many minds and enjoys the multi-disciplinary nature of team science and clinical medicine to channel the expertise of diverse professionals to tackle complex problems.
- BA: University of Pennsylvania (1993)
- Master of Science in Applied Physiology: Rosalind Franklin, University of Medicine and Science, The Chicago Medical School (1995)
- Doctor of Medicine: Rosalind Franklin, University of Medicine and Sceince, The Chicago Medicacl School (1999)
- Internal Medicine Residency: New York Presbyterian/Columbia Presbyterian Medical Center (2002)
- Infectious Diseases Fellowship: Brigham and Women’s Hospital and Massachusetts General Hospital (2004)
- Certificate in Clinical Effectiveness Program: Harvard University, School of Public Health (2004)
- Master of Science in Epidemiology and Preventive Medicine: Clinical Research Track, University of Maryland, School of Public Health, Department of Epidemiology (2022)
Infectious Diseases Clinic
620 South Taylor Ave., Suite 100
St. Louis, MO 63110
Associate Medical Director, HIV/Virology Clinic
- American Board of Internal Medicine, Subspecialty of Infectious Diseases
- American Board of Internal Medicine
- Lead Technical Advisor for AIDSRelief Zambia, University of Maryland School of Medicine, Institute of Human Virology, 2007-2008
- Zambian National Tuberculosis and Leprosy Program Committee, Ministry of Health, Guideline Committee Member, 2008
- Country Medical Director for AIDSRelief Tanzania, University of Maryland School of Medicine, Institute of Human Virology, 2008-2009
- Babiker A, Jeudy J, Kiperman S, Khambaty M, Shah A, and Bagchi S. Risk of Cardiovascular Disease due to Chronic Hepatitis C Infection: A Review. J Clin Transl Hepatol 2017; 5(4):1-20. doi: 10.14218/JCTH.2017.00021.
- Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, Longenecker CT, Strachan F, Bagchi S, Whiteley W, Rajagopalan S, Kottilil S, Nair H, Newby DE, McAllister DA, Mills NL. Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV. Circulation. 2018 Sep 11; 138(11):1100-1112. doi: 10.1161/CIRCULATIONAHA.117.033369.
- Jeudy J, Patel P, George N, Burrowes S, Husson J, Chua J, Conn L, Weiss RG, and Bagchi S. Assessment of coronary inflammation in antiretroviral treated people with HIV infection and active HIV/hepatitis C virus co-infection. AIDS 2022, 36:399–407.